Brad Stanfield: The ‘Toxic’ Hormone That Just Broke Every Obesity Record
B Brad Stanfield Video Summary · April 21, 2026 View Full Protocol → Key Takeaways Retatrutide, a triple hormone receptor agonist targeting GLP-1, GIP, and glucagon, produces unprecedented weight loss, averaging 24.2% of body weight at 48 weeks. Patients on retatrutide experienced up to 20.9% incidence of dysesthesia (abnormal skin sensations) at the highest dose,…
